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Abstract
Recent advances in transdermal drug delivery utilizing low-frequency sonophoresis (LFS) and
sodium lauryl sulfate (SLS) have revealed that skin permeability enhancement is not homogenous
across the skin surface. Instead, highly perturbed skin regions, known as localized transport
regions (LTRs), exist. Despite these findings, little research has been conducted to identify
intrinsic properties and formation mechanisms of LTRs and the surrounding less-perturbed non-
LTRs. By independently analyzing LTR, non-LTR, and total skin samples treated at multiple LFS
frequencies, we found that the pore radii (rpore) within non-LTRs are frequency-independent,
ranging from 18.2 – 18.5 Å, but significantly larger than rpore of native skin samples (13.6 Å).
Conversely, rpore within LTRs increases significantly with decreasing frequency from 161 Å, to
276 Å, and to ∞ (>300Å) for LFS/SLS-treated skin at 60 kHz, 40 kHz, and 20 kHz, respectively.
Our findings suggest that different mechanisms contribute to skin permeability enhancement
within each skin region. We propose that the enhancement mechanism within LTRs is the
frequency-dependent process of cavitation-induced microjet collapse at the skin surface, while the
increased rpore values in non-LTRs are likely due to SLS perturbation, with enhanced penetration
of SLS into the skin resulting from the frequency-independent process of microstreaming.
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INTRODUCTION
The use of ultrasound to increase skin permeability, referred to as sonophoresis, has
generated considerable interest and gained much use over the past few decades.1 Initial
research in the field was conducted at therapeutic frequencies, 1–3 MHz,2–4 while more
recent research efforts have focused on low-frequency sonophoresis (LFS), in the range 20–
100 kHz. This shift in frequencies was prompted by the discovery that cavitation is the
primary mechanism responsible for skin permeability enhancement.5–9 The observed
frequency dependence of cavitation occurs because of the inverse relationship between the
ultrasound frequency and the radii of the cavitation bubbles generated in the coupling
medium between the ultrasound horn and the skin.10–12 As the ultrasound frequency
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decreases, the radii of the cavitation bubbles tend to grow on average, resulting in more
forceful collapses when cavitation bubbles approach the surface of the skin. These transient
cavitation events near the skin surface have been identified as the primary mechanism of
skin permeability enhancement in response to LFS treatment.5,6,8
In addition to uncovering the connection between cavitation and skin permeability
enhancement, recent research has revealed many additional interesting phenomena. First, it
has been demonstrated that when LFS and chemical enhancers, especially surfactants, are
applied simultaneously during skin treatment, a synergistic enhancement is observed.6,13
This synergism can lead to an increase in skin conductivity or permeability by orders-of-
magnitude when compared to skin treated separately with LFS or chemical enhancers.13–15
Second, it has been shown that skin permeability enhancement by LFS and by LFS/SLS at
20 kHz is not homogenous.15–21 Instead, the LFS treatment generates discrete regions
within the skin, referred to as localized transport regions (LTRs), which are orders-of-
magnitude more permeable than the surrounding skin regions (non-LTRs) and native skin
samples.14 Furthermore, it has been shown that the non-LTRs also exhibit increased skin
permeability, with respect to native skin, when treated with 20 kHz LFS in combination with
the surfactant sodium lauryl sulfate (SLS).14,17,21 Accordingly, it was proposed that two
levels of enhancement are present in skin samples that are treated simultaneously with LFS
at 20 kHz and a chemical enhancer, such as SLS. The proposed existence of two levels of
enhancement on a single skin sample in response to LFS/SLS at 20 kHz suggests that
separate mechanisms of enhancement may operate within the LTRs and the non-LTRs, or
that an enhancement mechanism that is significant within the LTRs does not play a role
within the non-LTRs. This possibility motivates the need for a deeper understanding of the
transport pathways within LTRs and non-LTRs. In addition to quantifying the relative
extents of skin perturbation by measuring skin permeability and skin resistivity, it is possible
to utilize the aqueous porous pathway model22 and previously published masking
techniques14 to independently probe the effective pore radii in the LTRs and the non-LTRs.
In doing so, one may be able to provide deeper insight into the nature of the aqueous
transdermal pathways that exist within LTRs and non-LTRs, including the permeability
enhancement mechanisms that are most significant in each of these skin regions. Moreover,
because acoustic cavitation bubble collapse on the skin surface is a frequency-dependent
process,10–12 with the average cavitation bubble radius increasing with decreasing
ultrasound frequency, one would expect that the average pore radii in the skin regions where
such collapses occur would also increase with decreasing ultrasound frequency, if this
mechanism was present.
It is important to note that a previous study investigated the average pore radius of skin
treated with a range of LFS frequencies, in the context of the aqueous porous pathway
model.19 However, because that study did not independently study LTRs and non-LTRs, it
is significantly different than the study presented here. First, because the pore radii within
LTRs and non-LTRs were not studied separately, no direct conclusions could be reached
about the nature of the transport pathways or enhancement mechanisms within LTRs and
non-LTRs. Second, the ultrasound intensity used in the previous study was 1.08 W/cm2,
which is significantly lower than the 7.5 W/cm2 ultrasound intensity used in the experiments
reported here. Note that the ultrasound intensity used here is similar to those used in other
recent papers discussing LTR formation using LFS/SLS.14–17,23 Third, the range of skin
electrical resistivities investigated here is lower than that of the previous study, indicating
that the skin samples considered here are perturbed to a greater extent by the LFS/SLS
treatment than those considered in the prior study. In fact, because LTR size is closely
related to the extent of skin perturbation, as measured by skin resistivity,14 it is likely that
any LTRs that were formed would be much smaller than those observed in the study
reported here. Because the effects of the enhancement mechanisms are expected to be
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magnified under the ultrasound skin treatment conditions used in this study, relative to those
used previously, the combination of a higher ultrasound intensity and a greater extent of skin
perturbation by the LFS/SLS treatment utilized here should facilitate gaining insight into the
enhancement mechanisms at play within LTRs and non-LTRs, including the effect of the
ultrasound frequency on the resulting transdermal pathways in each skin region.
With all of the above in mind, the goals of this paper are four-fold: i) to demonstrate that at
the three ultrasound frequencies tested (20 kHz, 40 kHz, and 60 kHz), LTRs form on the
surface of the skin and exhibit increased permeability relative to both the non-LTRs and
native skin, ii) to demonstrate that at the three frequencies considered here there are two
levels of skin permeability enhancement relative to native skin when LFS and SLS are used
simultaneously, indicating that the non-LTRs also exhibit increased permeability relative to
native skin, iii) to better characterize the transport pathways through LTRs and non-LTRs by
independently determining the permeabilities and the effective aqueous pore radii in LTRs,
non-LTRs, and total skin samples in the context of the aqueous porous pathway model, and
iv) to propose mechanisms of enhancement within LTRs and non-LTRs.
MATERIALS AND METHODS
Chemicals
Phosphate buffer saline (PBS; 0.01 M phosphate, 0.137 M NaCl), calcein, and SLS were
obtained from Sigma Chemical Company (St. Louis, MO). The dye allura red (molecular
weight = 496 g/mol, water solubility = 225 g/L = 22.5 wt% at 25 °C, log KO/W =−0.550 24)
was obtained from TCI America (Portland, OR). C14-labeled SLS (specific activity of 55
mCi/mmol) was obtained from American Radiolabeled Chemicals (St. Louis, MO).
Soluene-350, a tissue solubilizer, and Hionic-Fluor, a scintillation cocktail, were obtained
from Perkin-Elmer (Waltham, MA). All chemicals were used as received.
Skin Preparation
Previously published protocols were utilized for the storage and preparation of skin samples.
22 A brief summary of these protocols follows. This procedure has been approved by the
MIT Committee on Animal Care. Skin was harvested from the back and flank of Female
Yorkshire pigs within 1 hour of sacrificing the animal. Subcutaneous fat was removed from
the skin using a razor blade and then sectioned into one-inch strips prior to storage at −85 °C
for up to 6 months. Before use in experiments, the skin was thawed for 1 hour in PBS and
then excess hair was trimmed using surgical scissors. The thawed skin was then cut into 25
mm by 25 mm samples. Before mounting of the skin samples into the 15-mm inner diameter
diffusion cells (PermeGear, Hellertown, PA), high vacuum grease (Dow Corning, Midland,
MI) was applied to the inner flange of the donor and the receiver compartments in order to
provide a water-tight seal between the skin and the diffusion cell. For additional mechanical
support, a 150-μm opening nylon mesh (Sefar Filtration, Depew, NY) was placed onto the
top of the receiver chamber of the diffusion cell. The receiver chamber was then filled with
PBS, the skin sample was mounted into the diffusion cell, and the diffusion cell was
clamped tightly. The donor chamber was then filled with the appropriate solution for
treatment or permeation experiments.
Skin Electrical Resistivity Measurements
The skin electrical resistivity, R, has been shown to be an accurate and instantaneous
indicator of the structural state of the skin.25,26 Previously published methods were followed
to measure R16,23,26 and are summarized next. A signal generator (Hewlett-Packard, model
HP 33120A) was used to generate an AC voltage at 100 mV and 10 Hz. The voltage was
applied across the skin using two Ag/AgCl electrodes (In Vivo Metrics, Healdsburgh, CA).
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The skin electrical current was measured using a multimeter (Fluke Corporation, Model
189) and the skin electrical resistance was calculated using Ohm’s Law. The background
resistance of the system was accounted for by removing the skin sample from the diffusion
cell and measuring the resistance of the system (note that this resistance is a function of the
area available for diffusion, therefore the background resistances for the LTRs and the non-
LTRs are not necessarily the same as that for the total skin samples). Subsequently, the
background resistance was subtracted from the resistance measured for the total system,
including the skin. R was then calculated by multiplying the skin electrical resistance by the
area of the skin sample. In order to ensure that the skin was intact prior to experimentation,
the initial R value of a skin sample was required to be above 50 kOhm·cm2.27–29 The
electrical current measured, and the resulting resistivity values, were calibrated by testing
the electrical equipment with resistors of known resistance.
Determination of Steady-State Calcein Permeabilities through the Skin
Calcein was chosen as a model aqueous permeant because its concentration in aqueous
solution can be determined with relative ease using simple spectrophotometric methods,
which minimizes sample preparation time and the cost of sample analysis. Calcein has also
been used in the past to determine skin permeabilities in the context of the aqueous porous
pathway model.14 The procedures described in the following sub-sections were carried out
on LTRs, non-LTRs, and total skin samples, as well as on native skin and skin dermis.
Pre-Treatment of Skin Samples by LFS/SLS—LFS/SLS pre-treatment of skin
samples was carried out according to previously published methods, which are summarized
next.14–17,22 Three separate ultrasound systems (Sonics and Materials, Inc., Newtown, CT)
were used in this study, each operating at a different frequency: 20 kHz (VCX 500), 40 kHz
(VCX 130), and 60 kHz (custom order). The intensity of each horn was calibrated using
calorimetry, and the skin treatment with each system was carried out under identical
experimental conditions: intensity − 7.5 W/cm2, duty cycle - 50% (5 s on, 5 s off), tip
displacement - 3 mm, and a coupling medium containing 1% (w/v) SLS and 0.025% (w/v)
allura red in PBS. Samples were treated with LFS until they reached pre-determined
electrical current thresholds of 225, 275, or 335 μA (±10%), which are similar to previously
published thresholds used when studying LTR formation.14,23 These thresholds were chosen
in order to: i) create LTRs that are sufficiently large to be quantifiable on a macroscopic
scale (at least 5% coverage of LTRs on the skin surface), and ii) study different levels of
skin perturbation. After each minute of LFS treatment, the coupling medium was changed in
order to minimize thermal effects (maintain the temperature within 10 °C of room
temperature), and the electrical current of the skin samples was measured to determine if the
target threshold had been reached. Upon completion of the LFS treatment, samples were
rinsed thoroughly with PBS, in order to remove all excess SLS from the skin surface, and
then the donor solution was replaced with 0.025% (w/v) allura red in PBS for 1 hour.
Because of the significantly higher permeability of LTRs, relative to non-LTRs (see Results
section), increased uptake of allura red occurs significantly only within LTRs during the
additional 1 hour soak, which aids in the subsequent digital imaging of the LTRs.
Digital Imaging and Analysis of LTR Areas—Digital imaging and analysis of LTRs
was conducted according to previously published protocols, which are summarized next.14
After the 1-hour soak in the allura red solution, the skin samples were thoroughly rinsed
with PBS and blotted dry. The skin samples were then imaged in triplicate using a digital
camera (HP Photosmart R967, 10 Megapixels, auto macro setting) at a distance of
approximately 8 inches above the sample. In order to correct for fluctuations in laboratory
lighting and infidelity of the charged coupled device, a red-colored strip was included in
each image as a standard (VWR, general-purpose laboratory labeling tape, color “red”).
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Images were then analyzed using the Corel Photo-Paint 11 Software Package (Corel
Corporation, Ontario, Canada) according to the method published by Kushner et al.14
Briefly, first the red-colored tape strip in each image was isolated in order to measure the
average blue-channel levels for all of the isolated strips. Then, the blue level for each image
was shifted using the “Contrast Enhancement” function to the average blue level for all
samples. After this standardization, the images were cropped to the size of the skin sample
treated by LFS (15 mm by 15 mm image size). Subsequently, the total number of pixels in
the image was noted using the “Histogram” function. In order to determine the size of the
LTRs, the “Threshold” function was used to tabulate the number of pixels having a blue-
channel level below 50. The reasons for the selection of these criteria are discussed further
in Kushner et al.14 It is important to note that the blue level threshold used in the current
study is different than that used by Kushner et al., because we utilized allura red to visualize
the LTRs instead of sulforhodamine B (SRB).14 SRB was not used in the present study
because a fluorescent dye was not required. It is then straightforward to calculate the area of
the LTRs on the skin surface, ALTR, in terms of the number of LTR pixels, the total number
of pixels in the image, and the total area of the image (Atotal =1.5 cm by 1.5 cm = 2.25 cm2).
Specifically,
(1)
Diffusion Masking Experiments—Diffusion masking is a previously published
method14 that allows one to probe the transport properties of the LTRs and the non-LTRs
separately. Use of this method allowed us to test three groups of samples at each ultrasound
frequency following pre-treatment with LFS/SLS: total, LTR, and non-LTR samples. Skin
samples in the total group were not masked (indicating that the entire skin surface was
available for calcein permeation). Skin samples in the LTR group had the non-LTR regions
masked in order to leave the LTR regions accessible for permeation of calcein (see Figure 1
for an image of a skin sample showing LTRs and non-LTRs). Similarly, skin samples in the
non-LTR group had the LTR regions masked in order to leave the non-LTR regions
accessible for permeation of calcein. The masking technique involves applying vacuum
grease to either the LTR or the non-LTR regions, respectively. The vacuum grease does not
allow diffusion of hydrophilic permeants through the skin regions that are masked with
vacuum grease. This method has been validated previously by Kushner et al.14
Calculating the Steady-State Calcein Permeability through the Skin—Following
imaging and masking, all skin samples were remounted into clean, dry diffusion cells. The
receiver chamber of each sample was filled with PBS (12 mL) and the donor chamber was
filled with 2.5 mL of 0.2% (w/v) calcein in PBS solution. These experiments were
conducted at room temperature (25 °C), and the receiver chambers were magnetically stirred
at 400 rotations per minute. Samples were allowed sufficient time to reach steady-state
(which has previously been established for calcein through porcine skin14), and then were
sampled at two-hour intervals between 18 – 26 hours after initiation of the experiments. For
each sample, a 1 mL aliquot was withdrawn from the receiver chamber and immediately
replaced with an equal volume of PBS. In addition, at each time interval, a 20 μL aliquot
was withdrawn from the donor chamber and diluted to 2 mL (in order for the absorbance to
be in the linear regime for calcein). The concentration of calcein in each aliquot was
determined using a UV/VIS spectrophotometer (Beckman Coulter DU 800) to measure
absorbance at λ = 494 nm and, subsequently, was converted to units of % (w/v) using a
standard curve generated from known concentrations of calcein.
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Finally, the permeability of calcein through the skin, P, was calculated at steady-state,
infinite sink conditions using the following equation:
(2)
where A is the area of skin available for permeation (which can vary with LTR area for the
masked samples, with A = 1.77 cm2 for the total skin samples), V is the volume of PBS in
the receiver chamber, Cd is the average calcein concentration in the donor chamber over the
sampling period, and (ΔC/Δt) is the rate of change of calcein concentration in the receiver
chamber (where replacement of the sampled aliquots by PBS is taken into account).
As previously noted, three main skin sample groups were studied: total samples, LTR
samples, and non-LTR samples. In addition, passive samples were also tested, which
involved no LFS/SLS pre-treatment, in order to compare the permeabilities of LTRs and
non-LTRs to that of native skin. Note that in the non-LTR and passive sample groups, it was
necessary to account for the background absorption of lipids in the receiver chamber in the
spectrophotometric analysis. It is well established that many epidermal and dermal
components have broad range absorption in the visible light range,30–34 which justifies the
need for this correction when the absorption of calcein is of similar, or of lower, magnitude
than the absorption of the skin components in solution at the wavelength of interest. This
procedure is described in Appendix A. Because there is a higher concentration of calcein
present in the receiver chambers of LTR samples, background absorption was found to be
insignificant within these samples and, therefore, there was no need to implement the
procedure described in Appendix A.
Calcein Permeability through the Skin Dermis—The final group of samples
consisted of skin that was first dermatomed (Zimmer Electric Dermatome, Model 8821,
Dover, OH) at a depth of 300 μm to completely remove the entirety of the epidermis from
the dermis. The epidermis was then discarded, and the calcein permeability and skin
electrical resistivity of the dermis were measured. Note that the calcein permeability and
skin electrical resistivity of the dermis are necessary in order to find the effective aqueous
pore radius of the dermis in the context of the aqueous porous pathway model (see “Theory”
section).22
Experiments with C14-Labeled SLS
In order to quantify the amount of SLS partitioning into the LTRs, the non-LTRs, and the
passive samples, the skin was pre-treated as described in the section “Pre-Treatment of Skin
Samples by LFS/SLS”, but the coupling medium also contained 0.5 μCi/mL C14-labeled
SLS, in addition to the 1% (w/v) SLS, and 0.025% (w/v) allura red in PBS. Skin samples
were treated with 20 kHz ultrasound for a total on time of 10 minutes (20 minutes at 50%
duty cycle), resulting in skin samples with an average current of 330 μA (within the range of
currents tested in the experiments used when calculating calcein permeabilities). Following
treatment, skin samples were rinsed with PBS, blotted dry with lab tissue, and then LTRs
(that were dyed red, see Figure 1) and non-LTRs (the undyed skin regions, see Figure 1)
were sampled using a circular cutting tool with an area of 7.9 mm2. On each skin sample, it
was typically possible to sample 2–3 LTR samples and 4–7 non-LTR samples (since the
non-LTRs occupy larger areas on the skin). The skin samples were then solubilized using
Soluene-350 (1.5 mL), and the amount of SLS was quantified using a Tri-Carb Liquid
Scintillation Counter (Perkin-Elmer), utilizing the scintillation cocktail Hionic-Fluor (5 mL).
This process was repeated for ten skin samples. Passive samples were contacted with the
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C14-labeled SLS-containing coupling medium for 20 minutes. For passive samples, the
entire skin sample that contacted the solution (with area of 1.77 cm2) was used to quantify
the amount of SLS in the skin. For the case of the larger passive samples, 5 mL of
Soluene-350 and 15 mL of Hionic-Fluor were utilized in the analysis of each sample. This
process was repeated for 20 skin samples. For all samples, the concentration of SLS in the
skin was normalized by the surface area of that sample.
In addition, to further test the mechanism of SLS penetration into non-LTRs, experiments
were conducted to quantify the penetration of SLS into the skin for two additional cases: i)
with increased temperature of the donor solution, and ii) with vigorous stirring in the donor
compartment of the diffusion cell. During ultrasound application, the temperature of the
donor solution increases linearly from room temperature (25 °C) by no more than 10 °C
during a two-minute treatment (with 50% duty cycle and 1-minute ultrasound ON time).
Therefore, to quantify the effect of just the temperature increase on SLS penetration into the
skin, an identical donor solution to that described above was initially heated to 37 °C (body
temperature and approximately 10 °C higher than room temperature) and was contacted with
the skin in two-minute increments (the same time interval corresponding to the ultrasound
experiments). The solution was replaced 10 times, with the 37 °C donor solution, for a total
contact time of 20 minutes. To test the effect of decreasing the concentration boundary layer
above the skin, an experimental setup was designed to allow for rapid stirring of the donor
solution above the skin. Samples were prepared by: i) placing a 12.5 mm stir bar (VWR) in
the donor compartment (having a diameter of 15 mm), ii) filling the donor compartment
with ~1.5 mL of C14-labeled SLS-containing coupling medium, and iii) capping the
diffusion cell with a plastic stopper (Chemglass, Vineland, NJ, part# CG-3021-01). Once the
samples were capped, the distance between the skin surface and the bottom of the stopper
was 5 mm. The diffusion cells were placed underneath a ¼” thick acrylic platform
(fabricated in-house) with a magnetic stir plate inverted on top of it (Corning, Lowell, MA,
model PC-410). Once the samples were placed under the magnetic stir plate, and the height
of the platform was adjusted so that it was resting on top of the diffusion cell, the magnetic
stir bar was attracted to the stir plate and therefore rested at the bottom of the plastic stopper
(5 mm above the skin surface). It was necessary that the stir bar not contact the skin during
mixing, because if the stir bar had rested on the skin surface, it could cause mechanical
abrasion of the skin due to friction. The stir plate was then set to its maximum speed, a
setting of “10”, and the experiment was allowed to proceed for 20 minutes. Although the
LFS/SLS experiments have an LFS ON time of 10 minutes (50% duty cycle), we observed
that fluid flow persisted in the donor compartment of the diffusion cell during the LFS OFF
time (that is, fluid flow did not cease immediately after LFS was turned off). Accordingly, to
better reproduce the environment above non-LTRs in the LFS/SLS experiments, the
vigorously-stirred experiments were conducted for 20 minutes (the full contact time of the
SLS donor solution with the skin during the LFS/SLS treatment). Both sets of samples were
prepared, and the amount of SLS quantified, in the same manner as described earlier in this
section for the passive samples contacted with C14-labeled SLS.
THEORY
Calculating the Effective Aqueous Pore Radius of the Skin
In order to calculate the effective aqueous pore radius (rpore) of the skin samples tested, we
utilized the aqueous porous pathway model.22 The main assumption of this model is that
aqueous permeants (in this case, calcein) traverse the skin along the same paths as the
current carrying ions of the electrolyte solution that the skin is immersed in (for PBS, the
dominant ions are Na+ and Cl−). This model utilizes hindered transport theory35 in order to
quantify the steric hindrance exerted by the finite-size skin pores on the flux of the aqueous
permeant and the current carrying ions through the skin. The hindrance factors
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corresponding to both species are related solely to the radius of each permeant and rpore.
Therefore, by equating the diffusion of the aqueous permeant, which is related to P, and of
the current carrying ions, which is related to R, one can determine rpore.
The relation between permeability, P, and skin electrical resistivity, R, in the context of the
aqueous porous pathway model, is given by:22
(3)
where C is defined as follows:
(4)
where z is the electrolyte valence, F is Faraday’s constant, cion is the electrolyte molar
concentration, e0 is the electronic charge, k is the Boltzmann constant, T is the absolute
temperature,  is the infinite-dilution diffusion coefficient of solute i, H (λi) is the
hindrance factor for solute i, and λi is defined as the ratio of the radius of solute i, ri, to the
radius of the aqueous skin pores, rpore.14 Although previous work has utilized older
expressions for the hindrance factor, H (λ),14,19,22,23,26,36,37 the most advanced expression
for H (λ), which has been used recently in the context of the aqueous porous pathway
model38 and is valid for λi ≤ 0.95, is given by:35
(5)
It is important to note that the only variable in Eq. (4) that depends on the intrinsic
properties of the skin is rpore. All the other variables are either constants or are properties of
the permeants used. Therefore, once an experimental C value is determined using Eq. (3),
rpore can be determined by iteratively solving Eq. (4) until C converges.
It is important to stress that, for any given aqueous permeant used (with given hydrodynamic
radius, which is 8 Å for calcein39), only a certain range of rpore values can be probed in the
context of the aqueous porous pathway model. In fact, for any permeant, there will be an
upper bound on the rpore values that can be determined depending on the hydrodynamic
radius of the permeant. This is due to the fact that, as the pores become increasingly large,
the extent of hindrance exerted by the pores on the diffusing permeant becomes increasingly
small as the hindrance factor approaches unity (recall that hindrance factors range from 0 to
1, where a hindrance factor of 1 corresponds to no hindrance and a hindrance factor of 0
corresponds to infinite hindrance). Beyond a certain rpore value, the hindrance exerted by the
pores on the permeant becomes statistically indistinguishable from the diffusion of the
permeant at infinite dilution, which corresponds to the upper bound of rpore that can be
probed with that permeant. This infinite-dilution limit (also known as an infinite-pore limit)
will be attained at lower rpore values for smaller permeants and will be higher for larger
permeants. This limit can be estimated in one of two ways: i) Assuming that, beyond a
certain rpore value, the hindrance factor calculated for calcein cannot be differentiated from a
hindrance factor of unity. In past publications, the level of uncertainty in the hindrance
factor was chosen to be 10%, and the pore radius corresponding to H (λ) = 0.9 was chosen as
the upper bound for a given permeant,22 or ii) Assuming that the pores within the
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hydrophilic dermis are infinite, and then using the pore radius calculated for the dermis in
the context of the aqueous porous pathway model as the upper limit on rpore. We tested both
methods, and they both yielded a similar upper limit of rpore for calcein, approximately 300
Å.
In order to apply the aqueous porous pathway model to our data, a linear regression was fit
to each set of log P versus log R values. For the model to be applicable, we required that the
95% confidence interval of the slope corresponding to every given data set includes the
theoretical value of −1 (see Eq. (3)). Once this test was carried out, and we confirmed that
the data was described by the aqueous porous pathway model, a C value was determined
using Eq. (3) for each data point tested. Subsequently, all of the individual C values within
each data set were averaged to yield the C value for that data set. This C value was then used
to calculate rpore in the manner described above. Therefore: i) the reported rpore value for a
given data set is calculated from the mean value of C for that data set, and ii) the 95%
confidence interval reported for rpore is calculated from the 95% confidence interval for C
for each data set. In general, all the statistical analyses reported in this study involve two-
sampled t-tests, at 95% confidence, unless noted otherwise.
Calculating the Skin Porosity-to-Tortuosity Ratio
In order to gain deeper insight into the transdermal pathways present within each skin
region, it is possible to again implement the aqueous porous pathway theory to calculate the
ratio between the skin porosity, ε, and the skin tortuosity, τ, using the following expression:
22
(6)
where the subscript i denotes a given skin sample, σsol is the electrical conductivity of PBS
(0.012 Ω−1cm−1),22 H (λion, i) is the hindrance factor for an ion calculated using Eq. (5), Ri
is the skin electrical resistivity, and Δx is the thickness of the skin layer that provides the
primary barrier to transport. For the non-LTRs and passive skin samples, Δx can adequately
be defined as the thickness of the stratum corneum, or 13.1 μm.40 Selecting an appropriate
Δx value for LTRs will be further discussed in the Results section.
RESULTS AND DISCUSSION
Dependence of the LTR, non-LTR, and Total Calcein Permeabilities on Electrical Current
Treatment Threshold and Ultrasound Frequency
Figure 2 shows the calcein permeability data for each of the three groups of samples tested
(total, LTR, and non-LTR) at the three ultrasound frequencies considered (A - 20 kHz, B -
40 kHz, and C - 60 kHz). In addition, the passive group is included in these figures for
comparison to the calcein permeability of native skin. As illustrated in Figure 2, at all three
frequencies, the permeability of calcein through the LTRs is much greater than those
through all the other skin regions. Additionally, we note that the permeability within LTRs
is of similar magnitude to the permeability within dermis samples (P = 1.8·10−2 cmhr,
calculated as described in the Materials and Methods section “Calcein Permeability through
the Skin Dermis”), suggesting that much of the barrier properties within the epidermis of
these regions has been overcome. These findings are consistent with previous results at 20
kHz.15 Moreover, at the three frequencies studied, the non-LTRs are also more permeable
than the native skin samples, which is consistent with earlier findings at 20 kHz.14,17,21 As
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expected, the calcein permeabilities of the total skin samples fall between those of the LTRs
and the non-LTRs at each of the three frequencies studied, because these samples contain
both types of skin regions.
Figure 2 also shows that for the total skin samples, at each of the three frequencies studied,
the calcein permeability increases linearly as a function of the skin electrical current
threshold (r2 =0.94–0.98). In spite of the observed upward linear trend in calcein
permeability for the total skin samples, the permeabilities within the LTRs and the non-
LTRs exhibit no dependence on the electrical current threshold based on statistical analysis
of the data at the three frequencies studied. This indicates that, as the electrical current
threshold increases, the permeability of the skin increases due to an increase in the area of
the LTRs present on the skin. This is clearly seen in Table 1, where the LTR area increases
with increasing skin electrical current threshold for the three frequencies studied.
Additionally, by comparing the calcein permeability of the total skin samples, at each
current threshold, as a function of ultrasound frequency, we see that the total calcein
permeabilities generally decrease with increasing ultrasound frequency (Figures 2A–C).
This suggests that the calcein permeation through the skin in the total skin samples is more
hindered with increasing frequency. This result will be discussed more thoroughly in the
context of the aqueous porous pathway model in the following sections.
Finally, by comparing the calcein permeability data in each skin region tested, one can
quantify the relative perturbation in these regions by calculating a permeability enhancement
ratio (P/Ppassive). In general, LTR samples are over four orders-of-magnitude more
permeable than native skin, and well over two orders-of-magnitude more permeable than
non-LTR samples. In addition, non-LTRs are over thirty-fold more permeable than native
skin. This again confirms the earlier finding that two levels of enhancement are observed
when treating skin simultaneously with LFS at 20 kHz and a chemical enhancer, such as
SLS.14,17,21 In the following sections, we will discuss in more detail possible causes leading
to the observed two levels of enhancement in the context of the effective aqueous skin pore
radii in the different skin regions.
Determining Effective Aqueous Pore Radii in LTRs, non-LTRs, and Total Skin Samples as
a Function of Ultrasound Frequency
Figure 3 shows the log P vs. log R plot used to analyze the 40 kHz LTR data in the context
of the aqueous porous pathway model. In order for the model to be applicable, it is first
necessary to check whether each data set’s linear regression has a slope that is not
statistically different (95% confidence) from the theoretical value of −1 (see “Theory”
section). The results of this analysis are reported in Table 2, which shows that all the data
sets have slopes that are within valid limits for the aqueous porous pathway model to be
applicable. The r2 values for all the data sets, except for the passive skin samples, are also
within the expected range reported in previously published data.22 Note that the low r2 value
exhibited by the passive skin sample set can be rationalized as follows. The skin resistivity
values for the passive skin samples are grouped very closely to each other, given the
resistivity of native skin and the fact that we require that the skin samples used possess
sufficiently high initial resistivity to ensure that they are not damaged. Therefore, any scatter
in the permeability data due to natural variations in the native skin has a very large effect on
the r2 value for this data set. Unlike in the LTR, non-LTR, and total skin samples, we are not
treating samples in a controlled manner to a pre-determined current threshold. Therefore, the
data is very susceptible to natural variations in the skin barrier, which can be significant
from sample-to-sample and especially between animals. Nevertheless, the passive skin
samples provide a good baseline for comparison to the values obtained in the case of the
LFS/SLS-treated skin samples and, therefore, have been included in Table 2.
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The rpore values corresponding to the different skin regions studied, calculated in the context
of the aqueous porous pathway model, are reported in Table 3. The total skin samples
clearly exhibit a decrease in rpore with increasing ultrasound frequency. Utilizing a two-
sample t-test at 95% confidence, we determined that, for the total skin samples, the
difference between rpore calculated at 20 kHz (105 Å) and 40 kHz (73.9 Å), and at 40 kHz
and 60 kHz (50.7 Å) are statistically significantly different. We also note that a previous
study by our group investigated the effect of different permeants on skin pore radii with 20
kHz LFS/SLS under nearly identical treatment conditions utilizing human skin.23 In this
study, the reported pore radii are very similar to the rpore value reported here for calcein
(molecular weight = 622.6 g/mol, rpore = 105 Å) at 20 kHz, for two other hydrophilic
permeants with molecular weights greater than 500 g/mol (for raffinose, rpore = 98 Å and for
inulin, rpore = 95 Å). Another recent study also found that the average pore radius for
porcine skin treated with 20 kHz LFS/SLS, under identical treatment conditions to those
utilized in this manuscript, is 113 Å, utilizing sucrose as a model hydrophilic permeant.38
This confirms that the data reported here at 20 kHz is consistent with the 20 kHz data
reported previously.
In order to explain the observed change in the rpore values with ultrasound frequency in the
total skin samples, it is revealing to examine the frequency dependence of the rpore values in
the LTRs and non-LTRs. Table 3 clearly shows that within the non-LTRs, rpore is
independent of the applied ultrasound frequency. Specifically, the rpore values in the non-
LTRs remain nearly constant, ranging from 18.2 – 18.5 Å for the three ultrasound
frequencies studied, with no statistically significant difference between the three samples.
However, these rpore values are statistically significantly larger than the rpore value observed
in the passive skin samples (rpore = 13.6 Å). We note that the rpore value for native skin that
we have determined is consistent with rpore values for native porcine skin reported in the
literature (11 – 28 Å).41–43 Although the calculated rpore values for both the non-LTRs and
native skin samples fall within the range of rpore values reported in the literature for native
skin, it is important to stress that, with very high statistical certainty (P<0.00001), the
calculated rpore values are in fact statistically significantly different in the non-LTR and
native skin samples. Accordingly, although there is a statistically significant enhancement in
rpore within the non-LTRs relative to the native skin samples, the rpore enhancement
observed within the non-LTRs is not frequency dependent. On the other hand, within the
LTRs, Table 3 clearly shows that there is a frequency dependence of rpore. Similar to what is
observed for the total skin samples, as the ultrasound frequency decreases, the rpore values
increase from 161 Å at 60 kHz, to 276 Å at 40 kHz, and then to ∞ (>300 Å, the upper-
bound for rpore values that can be probed with calcein) at 20 kHz. Because of the observed
frequency-independence of rpore in the non-LTRs discussed above, the LTR findings
suggests that the observed increase in the rpore values with decreasing ultrasound frequency
in the total skin samples is due primarily to the increase in the rpore values within the LTRs.
This result reflects the fact that the total skin samples consist of both LTRs and non-LTRs,
with the majority of permeant transport occurring through the LTRs. As a result, the total
skin samples exhibit a similar trend in rpore with ultrasound frequency as do the LTRs.
However, because the LTRs represent only a small fraction of the surface coverage of the
total skin samples (see Table 1), the average rpore values for the total skin samples are
significantly lower than those for the LTRs (see Table 3).
Mechanisms of Enhancement in the Non-LTRs of Skin Treated with LFS/SLS
Many mechanisms have been proposed and tested to establish if they play a significant role
in skin permeability enhancement with LFS. These include: i) acoustic cavitation in the
coupling medium above the skin (stable and transient),5,6,8,9,44 ii) thermal effects,9,44 and
iii) convection (microstreaming and resulting boundary-layer reduction).9,44 Of these, only
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transient cavitation has been consistently identified as the primary mechanism of skin
permeability enhancement in LFS, especially transient cavitation events near the surface of
the skin.5,8 These transient cavitation events near the skin surface can perturb the skin either
by: i) collapsing as a liquid microjet at the skin surface (either by impacting the skin or
impinging into the skin), or ii) spherical collapse near the skin surface (although it has been
suggested that spherical collapse close to a membrane may not be a physically achievable
process because the interaction between the membrane and the cavitation bubble will likely
cause non-linear, or non-spherical, oscillations).5,45 Note that cavitation within the skin has
been conclusively shown not to be a significant contributor to skin permeability
enhancement when utilizing LFS, but can contribute at higher frequencies.9 However, in
nearly all the mechanistic LFS studies cited, SLS was not utilized in the skin treatment
regimen. The absence of SLS is significant, because it has been shown at 20 kHz,17 and
confirmed in this paper at 20 kHz, 40 kHz, and 60 kHz, that two levels of enhancement are
present only when a chemical enhancer, such as SLS, is present in the coupling medium
during the LFS treatment. Furthermore, none of the mechanistic studies cited above have
independently considered LTRs and non-LTRs. In fact, many of these studies were carried
out before the existence of LTRs was discovered, including demonstrating that they are
regions of high permeability.14 For these reasons, it is possible that a mechanism that may
contribute to non-LTR permeabilization during the LFS/SLS treatment may have been
overlooked in earlier studies. With the above in mind, we next examine the previously
proposed mechanisms, in the context of our findings, to ascertain if they play a role in
permeability and pore radius enhancement within non-LTRs.
It is well established that acoustic cavitation is a frequency-dependent process.9,10
Accordingly, it is unlikely that cavitation plays a major role in the observed enhancements
within the non-LTRs, because we have found that the rpore values in the non-LTRs are
frequency-independent (see Table 3). This only leaves heating of the coupling medium and
microstreaming as potential mechanisms of enhancement in the non-LTRs. Because our
experiments involve a pre-treatment of the skin with LFS and SLS, the only role that heating
or microstreaming could play in permeability enhancement in the non-LTRs is to increase
the flux of SLS into the skin (note that calcein is not present during the LFS/SLS skin
treatment). This is because both heating of the coupling medium and microstreaming are not
present in the donor solution post-treatment, and there is no SLS present in the donor
solution during the steady-state calcein experiments. Furthermore, it has been shown that
ultrasound-induced microstreaming can produce significant agitation of aqueous systems,
leading to a decrease in the boundary layer above a membrane to an extent that the boundary
layer is insignificant when compared to the boundary layer under passive conditions.44 In
addition, heating is also known to increase permeant diffusion coefficients, and it is
therefore possible for this mechanism to increase the flux of SLS into the skin. This leads us
to propose that SLS is present in elevated amounts within non-LTRs compared to native
skin samples, but in far less amounts than in the highly-perturbed LTRs, due to a mechanism
such as microstreaming or heating that is not as significant as cavitation. This proposal is
consistent with previous findings, because it has been shown that LFS/SLS treatment of skin
increases the penetration of SLS into total skin samples,14,16 although these studies made no
distinction between penetration of SLS into LTRs and non-LTRs.
In order to test the hypothesis that there is increased uptake of SLS in the LTRs and non-
LTRs compared to the native skin samples, experiments were conducted (see Methods
section, “Experiments with C14 Labeled SLS”) to quantify the amount of SLS in LTRs, non-
LTRs, and passive skin samples. Additionally, two groups of samples were tested to isolate
the effects of vigorous stirring and heating in the donor solution during treatment. Figure 4
shows a comparison of the penetration of SLS into the non-LTRs with those of the
vigorously stirred, the heated, and the passive samples (note that the amount of SLS
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penetrating into the LTRs was not included in Figure 4, in order to more clearly compare the
mechanisms associated with SLS penetration into the non-LTRs). It was found that the
average amount of SLS in the non-LTRs, per unit area of skin, is 2.51·10−6 mmol/mm2,
which is nearly 2 times greater than that in the native skin samples (1.40·10−6 mmol/mm2).
In addition, the average amount of SLS in the LTRs (1.52·10−5 mmol/mm2), was found to
be 11-fold greater than that in the native skin samples. This strongly confirms our hypothesis
that SLS is present in increased levels in the non-LTRs compared to the native skin samples,
but in far smaller amounts than in the highly-perturbed LTRs. Furthermore, it was found that
the SLS concentration in the skin for the vigorously-stirred samples (2.49·10−6 mmol/mm2)
is statistically similar to that of the non-LTR samples (see 95% confidence intervals in
Figure 4). However, the samples whose donor solutions were heated to 37°C showed no
significant increase in SLS skin concentration (1.62·10−6 mmol/mm2) over the passive
samples (see 95% confidence intervals in Figure 4). Therefore, these findings suggest that
the dominant mechanism of SLS penetration into the non-LTRs is, in fact, microstreaming-
induced reduction of the boundary layer above these skin regions.
Additionally, it is well-established that the effect of SLS perturbation on skin can increase
rpore values. Ghosh et al. demonstrated that native skin soaked in PBS has an average pore
radius of 20±3 Å, while skin contacted with an SLS solution for five hours has an average
pore radius of 33±5 Å.41 This confirms that it is possible for rpore to increase solely due to
the exposure of the skin to SLS. Therefore, we propose that the observed increase in the
rpore values in the non-LTRs, and the resulting increase in calcein permeabilities, compared
to native skin, is due mainly to the ultrasound-frequency independent process of SLS acting
on these skin regions (note that the variability in native skin pore radius distribution may
also play a role), where increased penetration of SLS in the non-LTRs is the result of a non-
frequency-specific process such as microstreaming (and resulting boundary-layer reduction).
Furthermore, it is important to explain the origin of the observed >30-fold increase in
calcein permeability within the non-LTRs, relative to the passive calcein permeability. For
this purpose, we model the permeability of calcein through skin as follows:40
(7)
where Pcalcein, i is the calcein permeability through skin sample i, εi is the skin porosity of
sample i, τi is the skin tortuosity of sample i, and all the other variables were defined
previously.
Using Eq. (7) to calculate the permeability of calcein through the non-LTR samples, relative
to the passive permeability of calcein, and assuming that, in both the non-LTR and passive
skin samples, the stratum corneum is the primary barrier to transport (Δx is constant), one
obtains:
(8)
Equation (8) clearly shows that the calcein permeability in the non-LTRs can increase
relative to the passive calcein permeability due to: i) a decrease in calcein hindrance (due to
an increase in the radii of the skin pores), and ii) an increase in ε/τ. Both of these quantities
can be calculated utilizing Eqs. (5) and (8). Note that one can also use Eq. (6), in place of
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Eq. (8), to obtain very similar results when calculating the ratio of ε/τ in the non-LTRs and
passive skin samples. However, Eq. (8) was used for simplicity. First, we find that, over all
the non-LTR samples (recall that there is no frequency dependence within non-LTRs),
. This suggests that the ~35% increase in pore radius observed
within non-LTRs, compared to native skin, causes about a 4-fold decrease in calcein
hindrance through the skin pores. Next, using Eq. (8), we find that
. It is important to
note that the increase in pore radius that we have calculated for the non-LTRs is embedded
within ε/τ, since ε is defined as the area of pores on the skin divided by the total skin area.
Therefore, since we have found an approximately 35% increase in pore radius between the
non-LTR samples and native skin (18.4 Å and 13.6 Å, respectively), the increase in pore
radius can only account for about a 2-fold ( ) increase in ε/τ. However, we have
just shown that ε/τ increases nearly 9-fold between the non-LTRs and the native skin
samples. It therefore follows that the remaining ~4.5-fold increase in ε/τ must be due to
either the creation of new pores or to a decrease in τ. Furthermore, using the theoretical
derivation found in Kushner et al.,23 the following equation can be used to calculate the
ratio between τnon–LTR/τpassive:
(9)
where tlag is the lag time to reach steady-state diffusion and the remaining variables were
defined previously.
Using Eq. (9) for the non-LTR and passive skin samples, with Δxnon–LTR = Δxpassive, we
obtain the following result:
(10)
Then, substituting into Eq. (10), noting that tlag is simply the x-intercept on a plot of P vs.
time, one finds that . This
result implies that the tortuosity has decreased only slightly in the non-LTRs relative to the
passive skin samples. Therefore, the majority of the remaining 4.5-fold decrease in ε/τ must
be due to increases in porosity due to new pore creation. Nevertheless, it is important to
recognize that it is quite possible that SLS acting on the skin can, by itself, cause a change in
ε/τ. Indeed, it is well established that surfactants are potent transport enhancers, due to their
ability to solubilize/extract lipids and denature corneocytes (keratin fibers).46 In fact, in the
same study in which Ghosh et al. investigated the increase in pore radius of skin treated
passively with SLS,41 compared to PBS controls, these authors found that the ε/τ ratio
increased by nearly an order-of-magnitude within samples treated with SLS compared to
PBS controls, which is consistent with our findings in this study. One can certainly justify
the potential of SLS to create new pores on the skin (an increase ε) via the denaturation of
corneocytes, which is the most likely explanation for the observed increase in ε/τ based on
our findings above. However, more importantly, the analysis presented above confirms that
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the combined increases in H (λcalcein) and ε/τ can explain the observed >30-fold (4.1×8.8 =
36) increase in calcein permeability within the non-LTRs relative to native skin.
Mechanisms of Enhancement in the LTRs of Skin Treated with LFS/SLS
Turning our attention next to the observed trend in pore radii in the LTRs, as well as to the
related observed trend in the total skin samples, we have found that there is a strong
dependence of rpore on the ultrasound frequency (see Table 3). This immediately suggests
that cavitation is the primary mechanism of enhancement in the LTRs.10,12,47 It is also
worth stressing that several published papers have reported that transient cavitation events
near the surface of the skin are the primary mechanism of overall skin permeability
enhancement with LFS.5,6,8,9,44 One study in particular concluded that cavitation,
specifically in the vicinity of the skin, scales directly with overall calcein permeability
through rat skin.48 Accordingly, since we have already concluded that cavitation is not a
mechanism of enhancement in the non-LTRs, it follows that this mechanism must be the
primary enhancement mechanism in the LTRs.
Further examination of the LTR data in Table 3 shows that the same inverse relationship
between the cavitation bubble resonant radius and ultrasound frequency applies to the
variation of rpore with ultrasound frequency.10–12 More specifically, it is well-established
that the relationship between the ultrasound frequency (f) and the resonant bubble radius
(rres) satisfies the following relationship:12
(11)
where Csol is a constant that depends on the properties of the solution in which cavitation is
taking place.
Then, by proposing that cavitation microjet collapse onto the surface of the skin is the
primary mechanism of skin perturbation and, therefore, that rpore and rres are related
directly, we can verify whether the rpore values determined within the LTRs are consistent
with the expected variation between the cavitation bubble radius and the ultrasound
frequency. Using the same expression given in Eq. (11) to relate rpore and f for the 40 kHz
and 60 kHz LTR data, we verify that Csol, pore = rres,40kHz · 40kHz = rres,60kHz · 60kHz (to
less than 15% error), and we obtain an average Csol, pore value equal to 10.3 · 103 kHz · Å.
Using this Csol, pore value to calculate the expected rpore value at 20 kHz, we obtain a value
of 520 Å, which is greater than the infinite-pore limit that we calculated for calcein (rpore
>300 Å) and consistent with our data.
Similar to the non-LTR case, it is necessary to explain the origin of the observed increase in
calcein permeability within the LTRs (greater than 4 orders-of-magnitude), relative to the
passive calcein permeability. However, in the LTR case, because of the decreased barrier
properties of the stratum corneum, selecting a suitable value for Δx is more problematic.
Fortunately, however, Eq. (6) shows that ε/τ ~Δx, while Eq. (7) shows that P~(Δx)−1. As a
result, the dependence of permeability on Δx cancels out in Eq. (7). For simplicity, in the
following analysis we assume that, as is the case for non-LTRs and native skin, Δx is equal
to the thickness of the stratum corneum (as has been assumed in previous studies of
LTRs14). Using Eq. (7) for the LTRs and passive skin samples, we find that:
(12)
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Because the results of the analysis will change slightly based on the chosen frequency (recall
the frequency dependence of the pore radius within LTRs, see Table 3), we will consider
only the 40 kHz LTR data, since this data lies between the data at 20 kHz and 60 kHz.
Similar to the non-LTR analysis presented above, for the LTRs we find that:
 and . Using these results in Eq.
(12), we clearly see that these two effects account for the observed 4 orders-of-magnitude
(42×256 = 1.1 · 104) increase in calcein permeability. For completeness, it is important to
stress that either: i) we have underestimated the Δx value used for the LTRs, because the
predicted increase in ε/τ (256) is less than the increase expected solely from the 20-fold
(276/13.6 = 20, see Table 3) increase in pore radius calculated for the 40-kHz LTRs with
respect to native skin ( ), or ii) the number of pores within the LTRs has
decreased compared to native skin (this is not unreasonable, since the area of a single pore
has increased by 400-fold, and therefore, multiple native skin pores may have merged into a
single LTR pore). Note that, with respect to point (i), if a larger Δx value was chosen for the
LTR samples than for the passive skin samples, Eq. (12) would need to be modified as
follows:
(13)
However, as stated previously, this will have no effect on , but simply will
cause term 2 in Eq. (13) to decrease linearly with increasing ΔxLTR, while term 3 in Eq. (13)
will increase linearly with increasing ΔxLTR (recall that ε/τ ~ Δx, see Eq. (6)). Therefore, in
Eq. (13), the contributions of ΔxLTR in terms 2 and 3 will cancel each other. Furthermore, as
there is no rigorous method to estimate Δx more accurately, Eq. (13) provides no additional
useful information compared to Eq. (12). Also, we note that a similar analysis to that done
for the non-LTRs using Eqs. (9) and (10), in order to determine the relative contributions of
ε and τ, cannot be carried out for the LTRs because of our uncertainty in the precise value of
ΔxLTR. In any case, regardless of the value of ΔxLTR assumed, the analysis presented here
can explain the overall increase in calcein permeability observed within LTRs relative to
native skin, since  does not depend on the value of ΔxLTR chosen.
Finally, it is important to recognize that the rres values corresponding to the ultrasound
frequencies considered here are on the order of tens of microns, while the rpore values
calculated in Table 3 are on the order of tens of nanometers. This, however, does not affect
our conclusion that transient cavitation collapses near the skin surface are the primary cause
for the enlarged pores within LTRs. To reconcile the seemingly large difference between the
determined rpore values and the expected rres values at each frequency, we will identify the
reasons for this difference in the analysis that follows. First, it is well-known that the rres
values represent an upper bound on the average cavitation bubble size in aqueous solution.
49,50 For example, Burdin et al. and Tsochatzidis et al. showed that at 20 kHz, although rres
~ 150 μm, the average bubble radius was calculated to be between 3.15–5.25 μm, depending
on the measurement method and the applied ultrasound amplitude, or approximately 25- to
50-fold smaller than the resonant radius.49,50 In fact, one of the main conclusions of these
studies is that the mean measured bubble radius is much smaller than the resonant bubble
radius. Second, it has been observed that when transient cavitation bubbles collapse as
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microjets at an interface, the radius of the impinging microjet is about one order-of-
magnitude smaller than the radius of the collapsing cavitation bubble.45,51 Third, because
the skin is an elastic membrane, it is likely to rebound to some extent after a microjet
collapses on it. Although there has been no direct research into the actual physical size or
shape of the pores left in the skin by collapsing acoustic cavitation microjets, an interesting
analogy may be drawn to sharp punctures of the skin by needles and liquid jet injectors.
Significant research has been conducted on the penetration of soft solids, such as skin and
silicone rubbers, by sharp microscopic objects.52,53 For example, Shergold et al. found,
utilizing pig skin and silicone rubbers, that the ratio between the persistent defect left in the
skin and the diameter of a sharp tipped object was, in all cases, less than unity (tested for
diameters of 300 μm – 2.0 mm), with this ratio ranging between ~0.25–0.6 at the surface of
the samples.53 In addition, Roxhed et al. found that a microneedle, with a diameter of 108
μm, left a persistent hole in human skin of only 50 μm, leading these authors to conclude
that the persistent damage left in the skin was only about half of the microneedle’s shaft
diameter.54 This is relevant to the current analogy because it has recently been shown that
liquid jet injectors also penetrate, and damage, the skin in the same manner as sharp-tipped
objects puncturing soft materials, such as the skin.55 Liquid jet injectors transport fluid into
the skin by delivering a high-velocity liquid jet (100–200 m/s), having a radius as small as
15 μm, directed at the skin surface,56 much like an acoustic microjet delivers a liquid jet at
the surface of the skin (where the acoustic microjet is expected to have a diameter of ~1 μm
or less and have a maximum jet velocity of 153 m/s directed towards the skin45). Therefore,
the pore radius measured within LTRs are not necessarily equal to the actual radius of the
collapsing acoustic microjet itself, but instead, may be equal to the persistent radius of the
resulting pore left by the collapsing acoustic microjet. These three mechanisms combined
can account for the approximately three orders-of-magnitude difference observed between
the expected resonant bubble radii and the calculated rpore values.
Additional research is needed to show definitively that cavitation microjets directed at the
skin surface are the primary cause for the formation of pores within LTRs, which would
require imaging of the cavitation field above the skin and the pores left within the skin.
However, our findings, coupled with the mechanistic analysis described above, provide
compelling evidence that this enhancement mechanism is the most likely cause for the
observed trend in rpore values seen in the LTRs.
CONCLUSIONS
In this paper, we have shown that the pore radii in the non-LTRs are independent of
ultrasound frequency, ranging from 18.2 – 18.5 Å. In addition, we have determined that the
pore radii in the non-LTRs are statistically significantly larger than the rpore values for the
native skin samples (13.6 Å), suggesting that a frequency-independent enhancement process
is at play in these skin regions. Additional experiments were carried out to quantify the
amount of SLS penetrating into LTRs and non-LTRs relative to native skin, and we found
that nearly twice as much SLS penetrates into the non-LTRs per unit area than into native
skin. Furthermore, by studying different mechanisms of SLS penetration into skin, we have
shown that boundary-layer reduction caused by microstreaming is the most likely cause for
the increased SLS uptake within non-LTRs. Therefore, recognizing that SLS itself can
increase pore radii in the skin,41 we concluded that a frequency-independent process, such
as microstreaming, causes increased penetration of SLS into the skin, with SLS acting on the
skin being the main contributor to the observed increase in pore radius. In the LTRs, we
observed that the pore radii increase dramatically with decreasing frequency (161 Å, 276 Å,
and ∞ for 60 kHz, 40 kHz, and 20 kHz LFS, respectively). Accordingly, we have provided
strong support to the proposal that transient cavitation events near the skin surface, which
are known to be frequency dependent,10 are the primary mechanism of skin permeability
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enhancement in LTRs, which is consistent with previous literature findings.5,6,8,15,21 The
variation of the rpore values with ultrasound frequency in the LTRs also suggests that
transient cavitation microjets impinging on the skin surface can explain the observed values
of the pore radii.
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Appendix A – Correcting Sample Absorption Values to Account for Lipid
Absorption
A series of twenty negative controls were carried out, identical to the experimental protocol
described in the section “Calculating the Steady-State Calcein Permeability,” except that
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PBS was used in the donor chamber instead of 0.2% (w/v) calcein in PBS. This was done in
order to test if background species, such as skin lipids, could absorb in the receiver solution
at the maximum absorbance wavelength for calcein (λ = 494 nm). We found that there is
time-dependent absorbance at a wavelength of 494 nm for the negative controls. However,
the level of absorbance was such that it only affected calcein permeability values
significantly (>5%) when the total absorbance in the samples containing calcein was below
0.4. Therefore, only the non-LTR samples and the passive control samples were found to be
affected significantly by background lipid absorption at 494 nm.
In order to properly account for background lipid absorption in the affected samples, the
absorbance intensity as a function of wavelength was measured, in the range 420 nm – 550
nm, for the negative control samples and for samples containing known concentrations of
pure calcein. Figure 5 shows the variation of the absorbance with wavelength in: negative
control samples containing skin lipids (Figure 5A), samples containing solely calcein
(Figure 5B), and non-LTR samples containing a mixture of skin lipids and calcein (Figure
5C). One can clearly see that the curve in Figure 5C is a simple combination of the curves in
Figures 5A and 5B.
Unfortunately, the variation in the absorption between samples for the negative controls was
too large to simply average the lipid absorption at each sampling time point and then
subtract it from the non-LTR and the passive sample data. Fortunately, however, the
background absorption for all the negative control samples were found to have similar
shapes, indicating that the absorption curve for any of these samples could be reproduced by
multiplying a standard background curve (which was generated by averaging the lipid
absorption at each wavelength over all the negative control samples) by a constant parameter
associated with that given sample. Specifically,
(A1)
where Ai (λ)is the absorption of sample i at a given wavelength (λ) between 420 – 550 nm, ci
is the constant background parameter associated with that sample, and Asc (λ)is the
absorption at a given wavelength for the standard curve.
Therefore, the entire background curve for any sample can simply be defined by a single
parameter. In addition, in the negative control samples this parameter is essentially
wavelength independent in the relevant range of 420 nm – 550 nm. This indicates that one
can extract the background absorbance parameter at any wavelength, or range of
wavelengths, and still reconstruct the entire background absorbance curve for the range of
wavelengths between 420 nm and 550 nm.
An examination of the plots in Figure 5 shows that in the range 420–430 nm and 540–550
nm there is much larger absorption in the background curve (Figure 5A) than in the pure
calcein curve (Figure 5B). As a result, the curve in Figure 5C closely resembles Figure 5A
in these two regions. Therefore, in order to decompose a curve like that in Figure 5C into its
corresponding background curve (Figure 5A) and pure calcein curve (Figure 5B), the
background absorbance parameter was calculated in the range 420–430 nm and 540–550 nm
by dividing the absorbance in these regions by the absorbance for that wavelength in the
standard background curve. Subsequently, the simple arithmetic mean of these twenty-two
values was calculated to obtain the background absorbance parameter for that sample, and
the background curve was reconstructed by multiplying the calculated parameter by the
standard background curve. The calculated background curve (such as Figure 5A) was then
subtracted from the total curve (such as Figure 5C) in order to construct a pure calcein curve
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(such as Figure 5B) for that sample. The resulting curve was then used to calculate the
concentration of calcein in the receiver chamber.
In order to validate that the decomposition method described above yields reproducible and
reliable calcein concentrations, a series of 10 samples with predetermined absorption
profiles of background lipids and predetermined absorption profiles of pure calcein were
mixed. The actual concentration of calcein was compared to the value obtained using our
decomposition method, and the difference between the calcein concentration calculated by
the decomposition method and the actual calcein concentration in each case was found to be
less than ~5%, thereby validating this method.
Polat et al. Page 22
J Pharm Sci. Author manuscript; available in PMC 2012 February 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
Porcine skin sample treated with LFS/SLS at 40 kHz. Regions of the skin dyed red are
LTRs, regions of the skin that are not dyed red are non-LTRs. The diameter of the circular
sample is 15 mm.
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Figure 2.
Calcein Permeability for the total, LTR, non-LTR, and passive skin samples treated to
electrical current thresholds of 225 μA, 275 μA, and 335 μA at the three ultrasound
frequencies considered: 20 kHz (A), 40 kHz (B), and 60 kHz (C). Key: Total group (□);
LTR group( ); Non-LTR group (▧); Passive group (■). Error bars = ±1 SD. Each bar in
each graph represents 8–12 samples, except for the passive group where the sample size is
20.
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Figure 3.
Sample log P vs. log R plot. Data shown (□) is for LTR samples treated at 40 kHz. Units of
P are cm/hr and units of R are kOhm·cm2. Key: solid black line – linear regression of the
data, gray line – linear regression with theoretical slope of −1.
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Figure 4.
Concentration of SLS in skin treated under different experimental conditions in the donor
solution, compared to that of non-LTRs. In each case, the total concentration of SLS in the
donor solution was 1% (w/v), but stirring and heating (37° C) were varied in order to assess
the importance of these two processes on SLS penetration within non-LTRs. Error bars
shown are 95% confidence intervals.
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Figure 5.
Absorption as a function of wavelength, in the range 420 – 550 nm, for: a background
sample containing skin lipids (A), a pure calcein sample (B), and a non-LTR sample
containing both calcein and skin lipids (C).
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